Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Intron retention is a widespread mechanism of tumor-suppressor inactivation
Hyunchul Jung, Donghoon Lee, Jongkeun Lee, et al.
Nature Genetics (2015) Vol. 47, Iss. 11, pp. 1242-1248
Closed Access | Times Cited: 338

Showing 1-25 of 338 citing articles:

Detection and localization of surgically resectable cancers with a multi-analyte blood test
Joshua D. Cohen, Lu Li, Yuxuan Wang, et al.
Science (2018) Vol. 359, Iss. 6378, pp. 926-930
Open Access | Times Cited: 2282
Predicting Splicing from Primary Sequence with Deep Learning
Kishore Jaganathan, Sofia Kyriazopoulou Panagiotopoulou, Jeremy F. McRae, et al.
Cell (2019) Vol. 176, Iss. 3, pp. 535-548.e24
Open Access | Times Cited: 1909
Improving genetic diagnosis in Mendelian disease with transcriptome sequencing
Beryl B. Cummings, Jamie L. Marshall, Taru Tukiainen, et al.
Science Translational Medicine (2017) Vol. 9, Iss. 386
Open Access | Times Cited: 689
RNA splicing factors as oncoproteins and tumour suppressors
Heidi Dvinge, Eun Hee Kim, Omar Abdel‐Wahab, et al.
Nature reviews. Cancer (2016) Vol. 16, Iss. 7, pp. 413-430
Open Access | Times Cited: 602
Roles and mechanisms of alternative splicing in cancer — implications for care
Sophie Bonnal, Irene López‐Oreja, Juan Valcárcel
Nature Reviews Clinical Oncology (2020) Vol. 17, Iss. 8, pp. 457-474
Closed Access | Times Cited: 556
The Functional Impact of Alternative Splicing in Cancer
Héctor Climente-González, Eduard Porta‐Pardo, Adam Godzik, et al.
Cell Reports (2017) Vol. 20, Iss. 9, pp. 2215-2226
Open Access | Times Cited: 506
Therapeutic targeting of splicing in cancer
Stanley Chun-Wei Lee, Omar Abdel‐Wahab
Nature Medicine (2016) Vol. 22, Iss. 9, pp. 976-986
Open Access | Times Cited: 502
Somatic Mutational Landscape of Splicing Factor Genes and Their Functional Consequences across 33 Cancer Types
Michael Seiler, Shouyong Peng, Anant A. Agrawal, et al.
Cell Reports (2018) Vol. 23, Iss. 1, pp. 282-296.e4
Open Access | Times Cited: 397
Full-length transcript characterization of SF3B1 mutation in chronic lymphocytic leukemia reveals downregulation of retained introns
Alison D. Tang, Cameron M. Soulette, Marijke J. van Baren, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 388
Genomic basis for RNA alterations in cancer
Claudia Calabrese, Natalie R. Davidson, Deniz Demircioğlu, et al.
Nature (2020) Vol. 578, Iss. 7793, pp. 129-136
Open Access | Times Cited: 355
Lessons from non-canonical splicing
Christopher R. Sibley, Lorea Blázquez, Jernej Ule
Nature Reviews Genetics (2016) Vol. 17, Iss. 7, pp. 407-421
Open Access | Times Cited: 284
Aberrant RNA Splicing in Cancer
Luisa F. Escobar‐Hoyos, Katherine Knorr, Omar Abdel‐Wahab
Annual Review of Cancer Biology (2018) Vol. 3, Iss. 1, pp. 167-185
Open Access | Times Cited: 284
Intron retention as a component of regulated gene expression programs
Aishwarya G. Jacob, Christopher W. J. Smith
Human Genetics (2017) Vol. 136, Iss. 9, pp. 1043-1057
Open Access | Times Cited: 278
Alternative tumour-specific antigens
Christof C. Smith, Sara R. Selitsky, Shengjie Chai, et al.
Nature reviews. Cancer (2019) Vol. 19, Iss. 8, pp. 465-478
Open Access | Times Cited: 277
Intron retention is a source of neoepitopes in cancer
Alicia Smart, Claire A. Margolis, Harold Pimentel, et al.
Nature Biotechnology (2018) Vol. 36, Iss. 11, pp. 1056-1058
Open Access | Times Cited: 261
IRFinder: assessing the impact of intron retention on mammalian gene expression
Robert Middleton, Dadi Gao, Aubin Thomas, et al.
Genome biology (2017) Vol. 18, Iss. 1
Open Access | Times Cited: 249
RNA splicing dysregulation and the hallmarks of cancer
Robert K. Bradley, Olga Anczuków
Nature reviews. Cancer (2023) Vol. 23, Iss. 3, pp. 135-155
Open Access | Times Cited: 246
Systematic Analysis of Splice-Site-Creating Mutations in Cancer
Reyka G. Jayasinghe, Song Cao, Qingsong Gao, et al.
Cell Reports (2018) Vol. 23, Iss. 1, pp. 270-281.e3
Open Access | Times Cited: 221
Alternative mRNA splicing in cancer immunotherapy
Luke Frankiw, David Baltimore, Guideng Li
Nature reviews. Immunology (2019) Vol. 19, Iss. 11, pp. 675-687
Closed Access | Times Cited: 215
Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers
Yuxuan Wang, Lu Li, Christopher Douville, et al.
Science Translational Medicine (2018) Vol. 10, Iss. 433
Open Access | Times Cited: 205
The role of alternative splicing in cancer: From oncogenesis to drug resistance
Rocco Sciarrillo, Anna Wojtuszkiewicz, Yehuda G. Assaraf, et al.
Drug Resistance Updates (2020) Vol. 53, pp. 100728-100728
Open Access | Times Cited: 191
RNA Splicing and Cancer
Eric Wang, Iannis Aifantis
Trends in cancer (2020) Vol. 6, Iss. 8, pp. 631-644
Closed Access | Times Cited: 184
Intron retention in mRNA: No longer nonsense
Justin Wong, Amy Au, William Ritchie, et al.
BioEssays (2015) Vol. 38, Iss. 1, pp. 41-49
Closed Access | Times Cited: 180
Alternative Splicing and Protein Diversity: Plants Versus Animals
Saurabh Chaudhary, Waqas Khokhar, Ibtissam Jabre, et al.
Frontiers in Plant Science (2019) Vol. 10
Open Access | Times Cited: 169
To NMD or Not To NMD: Nonsense-Mediated mRNA Decay in Cancer and Other Genetic Diseases
Fran Supek, Ben Lehner, Rik G.H. Lindeboom
Trends in Genetics (2020) Vol. 37, Iss. 7, pp. 657-668
Open Access | Times Cited: 168
Page 1 - Next Page

Scroll to top